Overview of Dr. Saeed
An associate member at Moffitt cancer center specializing in the treatment of Hodgkins, T cell and B cell lymphoma.
Office
12902 Magnolia Dr.
Tampa, FL 33612Fax+1 813-745-3875
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016- University of Kentucky College of MedicineResidency, Internal Medicine, 2010 - 2013
University of Baghdad College of MedicineClass of 2006
Certifications & Licensure
FL State Medical License 2019 - 2025
KY State Medical License 2013 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- AACR/ASCO Clinical trial workshop in Vail,CO AACR/ASCO, 2016
- Letter of Achievement UK hematology oncology fellowship program, 2015-2016
- Clinical trial boot camp Markey Cancer Center, 2014
- Join now to see all
Clinical Trials
- Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma Start of enrollment: 2018 Dec 19
Publications & Presentations
PubMed
- 86 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson
Journal of the National Comprehensive Cancer Network. 2021-11-01 - 147 citationsCopper deficiency anemia: review article.Zin W. Myint, Thein Hlaing Oo, Kyaw Zin Thein, Aung M. Tun, Hayder Saeed
Annals of Hematology. 2018-06-29 - 13 citationsDefining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.Hayder Saeed, Dima Hnoosh, Bin Huang, Eric B. Durbin, Patrick C. McGrath
Journal of Surgical Oncology. 2016-09-01
Journal Articles
- Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
Abstracts/Posters
- Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-RHayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt ExperienceHayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Authored Content
- Unleashing the Spark: My Top #ASH23 Posts That Ignited EngagementDecember 2023
- Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?December 2022
- An Update on T Cell Lymphoma from SOHO 2021September 2021
Press Mentions
CME Information - May 2018January 28th, 2018
Professional Memberships
- Fellow
- Member
Other Languages
- Arabic
External Links
- Pubmed Profilehttp://goo.gl/3BmVhl
- Twitter https://twitter.com/HayderSaeed_MD
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
